Skip to main content

Table 13 Difference in means between treatment and control groups for DBP at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author Sample size (treatment group vs. control group) Difference 95% CI
Liu et al. [64] 119 (60 vs. 59) − 1.00 mmHg** − 3.34 to 1.34
Mainenti et al. [65] 23 (11 vs. 12) − 5.4 mmHg* − 11.08 to 0.28
Monzani et al. [67] 20 (10 vs. 10) 3.80 mmHg* − 2.42 to 10.02
Monzani et al. [68] 45 (23 vs. 22) − 3.00 mmHg* − 7.97 to 1.97
Nagasaki et al. [69] 95 (48 vs. 47) − 0.10 mmHg** − 4.22 to 4.02
Stott et al. [73] 638 (318 vs. 320) − 0.1 mmHg* − 1.5 to 1.3
Yazici et al. [76] 45 (23 vs. 22) − 0.50 mmHg* − 5.53 to 4.53
Zhao et al. [77] 369 (210 vs. 159) − 0.13 mmHg* − 2.42 to 2.16
  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group